Stem Cell Based Diabetes Treatment: Alan Lewis - CIRM Science Writer's Seminar

Alan Lewis, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. At the time of this presentation Alan Lewis was president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes. Viacyte Inc. has four CIRM grants to help get a stem cell based therapy for diabetes to the FDA for clinical trials.

© 2013 California Institute for Regenerative Medicine